New Funding: Rosemary extract and carnosic acid to be studied for breast cancer

rosemary extract carnosic acid

Our laboratory has been especially interested in the rosemary plant for its health promoting properties.

My first original research paper evaluated carnosol, an antioxidant diterpene, that is isolated from rosemary in the journal of Pharmaceutical Research

This research served as a starting point to expand our research to prostate cancer and colitis and most recently breast cancer.

In this new research project funded by the NCI we will be investigating the pharmacokinetics and efficacy of rosemary extract and carnosic acid in a breast cancer model. 

The total funding for this project over the next 2 years will help determine if rosemary extract should be studied in clinical trials for breast cancer prevention.  

We also have a research project funded by the USDA evaluating rosemary extract used as a food preservative to prevent colitis.  You can read more about how rosemary extract can be used as a food preservative here

Previously we published an article the journal Cancer Letters titled, “Carnosol: a promising anti-cancer and anti-inflammatory agent

About the author

Dr. Johnson received his PharmD and PhD at the University of Wisconsin where he also completed a clinical research fellowship evaluating phytochemicals and botanical extracts. He is an associate professor and licensed pharmacist he offers a unique perspective on the most current scientific literature related to the health and nutrition. His research program is active and has led to more than 50 publications and published abstracts related to the health promoting properties of natural products, phytochemicals and plant extracts. He has presented some of his research findings at international scientific meetings in the US, Italy, Austria, Israel, France, China, Philippines and Turkey.